Immunotherapy

Lung Cancer

EDU 35 - (INTERACTIVE) New Combinations of Radiation and Systemic Therapies in Lung Cancer: Chemotherapy, Targeted Agents and Immunotherapy

10/24/2018
7:45 AM - 9:00 AM
Location: Room 006

Session Type: Educational
1.25 AMA PRA Category 1 Credits™
1.25 CAMPEP Credits
1.50 MDCB Credits

Recent advances in radiation therapy techniques and the success of new systemic therapies, such as targeted agents and immunotherapy, have improved outcomes for many patients with lung cancer. Despite these successes, the efficacy and safety of combining radiation with newer systemic agents, including in patients receiving SBRT or hypofractionation, remain an active area of investigation.

This session will review the current state of knowledge on combining systemic agents, including chemotherapy, targeted agents, and immunotherapy, with conventional and hypofractionated radiation. The faculty will also discuss ongoing and proposed studies on this topic.

Following the session, attendees should be able to identify new systemic therapies for lung cancer, to discuss how these therapies can affect radiation planning and treatment, toxicities, and cancer outcomes, and to apply this knowledge when evaluating treatment options and making treatment decisions for their patients.

Learning Objectives:

Presentations:

Aileen Chen, MD

Dana-Farber Cancer Institute

Disclosure:
Employment
Dana-Farber Cancer Institute: Employee, Attending physician: Employee

Presentation(s):

Send Email for Aileen Chen


Assets

EDU 35 - (INTERACTIVE) New Combinations of Radiation and Systemic Therapies in Lung Cancer: Chemotherapy, Targeted Agents and Immunotherapy



Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for EDU 35 - (INTERACTIVE) New Combinations of Radiation and Systemic Therapies in Lung Cancer: Chemotherapy, Targeted Agents and Immunotherapy